Items per page
Sort by

Send to:

Choose Destination

Results: 8

PubMed Links for Books (Select 2995850)


Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy.

Denmeade SR, Mhaka AM, Rosen DM, Brennen WN, Dalrymple S, Dach I, Olesen C, Gurel B, Demarzo AM, Wilding G, Carducci MA, Dionne CA, Møller JV, Nissen P, Christensen SB, Isaacs JT.

Sci Transl Med. 2012 Jun 27;4(140):140ra86. doi: 10.1126/scitranslmed.3003886. Erratum in: Sci Transl Med. 2012 Jul 18;4(143):143er4.


GCPII imaging and cancer.

Foss CA, Mease RC, Cho SY, Kim HJ, Pomper MG.

Curr Med Chem. 2012;19(9):1346-59. Review.


A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA).

Banerjee SR, Pullambhatla M, Shallal H, Lisok A, Mease RC, Pomper MG.

Oncotarget. 2011 Dec;2(12):1244-53.


2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.

Chen Y, Pullambhatla M, Foss CA, Byun Y, Nimmagadda S, Senthamizhchelvan S, Sgouros G, Mease RC, Pomper MG.

Clin Cancer Res. 2011 Dec 15;17(24):7645-53. doi: 10.1158/1078-0432.CCR-11-1357. Epub 2011 Oct 31.


Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.

Chen Y, Foss CA, Byun Y, Nimmagadda S, Pullambhatla M, Fox JJ, Castanares M, Lupold SE, Babich JW, Mease RC, Pomper MG.

J Med Chem. 2008 Dec 25;51(24):7933-43. doi: 10.1021/jm801055h.


N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.

Mease RC, Dusich CL, Foss CA, Ravert HT, Dannals RF, Seidel J, Prideaux A, Fox JJ, Sgouros G, Kozikowski AP, Pomper MG.

Clin Cancer Res. 2008 May 15;14(10):3036-43. doi: 10.1158/1078-0432.CCR-07-1517.


Clinical trials of cancer therapies targeting prostate-specific membrane antigen.

Olson WC, Heston WD, Rajasekaran AK.

Rev Recent Clin Trials. 2007 Sep;2(3):182-90. Review.


Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction.

Conway RE, Petrovic N, Li Z, Heston W, Wu D, Shapiro LH.

Mol Cell Biol. 2006 Jul;26(14):5310-24.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk